FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma
Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer
Gleevec First Pediatric Cancer Approval By FDA In 13 Years
FDA Clears Rapid Test For Aspergillus Infection
New Agent Targets Glioma Tumor Cells Prior To Surgery
Fruits, Vegetables Protective Against Cancer, IARC Says
Heavy Smokers And Drinkers Have Different Brain Chemistry
NCI-Approved Clinical Trials
Trending Stories
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - Thomas B. Tomasi Jr., Roswell Park president and CEO from 1986 to 1996, dies at 97
An architect of today’s Roswell Park
